title: Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred.
abstract: Periodic paralysis, cardiac arrhythmia and bone features are the hallmark of Andersen's syndrome (AS), a rare disorder caused by mutations in the KCNJ2 gene that encodes for the inward rectifier K(+)-channel Kir2.1. Rest following strenuous physical activity, carbohydrate ingestion, emotional stress and exposure to cold are the precipitating triggers. Most of the mutations act in a dominant-negative fashion, either through a trafficking dysfunction or through Kir2.1-phosphatidyl inositol bisphosphate binding defect. We have identified two families that were diagnosed with periodic paralysis and cardiac abnormalities, but only discrete development features. The proband in one of the two families reported having his symptoms occurring twice within the day following corticosteroids ingestion, and alleviated after stopping the corticosteroid treatment. Electromyographic evaluations pointed out to a typical hypokalemic periodic paralysis pattern. Molecular screening of the KCNJ2 gene identified two mutations leading to C54F and T305P substitutions in the Kir2.1 protein. Functional expression in mammalian cells revealed a loss-of-function of the mutated channels and a dominant-negative effect when both mutants and wild-type channels are present in the same cell. However, channel trafficking and assembly are not affected. Substitutions at these residues may interfere with phosphatidyl inositol bisphosphate binding to Kir2.1 channels. Sensitivity of our patients to multiple corticosteroid administrations shows that care must be taken in the use of such treatments in AS patients. Taken together, our data suggest the inclusion of the KCNJ2 gene in the molecular screening of patients with periodic paralysis, even when the classical AS dysmorphic features are not present.
authors.affiliation: Institut de Pharmacologie Moléculaire et Cellulaire, UMR 6097 CNRS, Université de Nice Sophia Antipolis, France. bendahhou@ipmc.cnrs.fr
authors.forename: Saïd
authors.initials: S
authors.lastname: Bendahhou
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Fournier
authors.forename: Serge
authors.initials: S
authors.lastname: Gallet
authors.forename: Dominique
authors.initials: D
authors.lastname: Ménard
authors.forename: Marie-Madeleine
authors.initials: MM
authors.lastname: Larroque
authors.forename: Jacques
authors.initials: J
authors.lastname: Barhanin
mesh_terms: D000305:Adrenal Cortex Hormones / Q000009:adverse effects*; D000328:Adult; D000595:Amino Acid Sequence; D050030:Andersen Syndrome / Q000150:complications* / Q000175:diagnosis* / Q000235:genetics; D000818:Animals; D019556:COS Cells; D002522:Chlorocebus aethiops; D004576:Electromyography; D005260:Female; D005799:Genes, Dominant; D006801:Humans; D008297:Male; D008958:Models, Molecular; D008969:Molecular Sequence Data; D009154:Mutation; D010375:Pedigree; D010641:Phenotype; D024661:Potassium Channels, Inwardly Rectifying / Q000235:genetics / Q000378:metabolism; D017386:Sequence Homology, Amino Acid; D014018:Tissue Distribution
chemical_list: D000305:Adrenal Cortex Hormones; C489457:KCNJ2 protein, human; D024661:Potassium Channels, Inwardly Rectifying